Baird Medical Investment Holdings Limited(BDMD)Earnings, Financials & Key Ratios
BDMD•NASDAQ
$1.18
Price updated Jul 7, 2026
AboutBaird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.Show more
- Revenue$23M-39.2%
- EBITDA-$24M-245.2%
- Net Income-$27M-319.0%
- EPS (Diluted)-0.98-300.0%
- Gross Margin83.79%-5.0%
- EBITDA Margin-108.41%-338.7%
- Operating Margin-113.31%-374.0%
- Net Margin-121.04%-460.0%
- ROE-76.86%-332.9%
BDMD Price & Volume
Baird Medical Investment Holdings Limited (BDMD) stock price & volume — 10-year historical chart
Loading chart...
Severe Revenue Contraction Threatens Operational Solvency
Investment Thesis • Updated 2025Q4
VerdictNegative: The company's precarious liquidity position
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Existential liquidity and solvency
Key Thesis Takeaways
- Baird Medical faces a critical inflection point as its 39.0% year-over-year revenue decline in 2025Q4 highlights significant structural headwinds in its microwave ablation business.
- Despite maintaining elite gross margins of 84.7%, the company's inability to control operating expenses, which resulted in a -104.1% operating margin, suggests a fundamental misalignment between its cost structure and market demand.
- Investors should exercise extreme caution given the precarious liquidity position, characterized by a cash balance of only $178,321 against a quarterly net loss of $16.0 million.
Verdict Logic
evidenced by a cash balance of only $178,321 against a $16.0 million quarterly net loss, presents an existential risk to shareholders.
BDMD Growth Metrics
Baird Medical Investment Holdings Limited (BDMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years4.46%
3 Years-13.72%
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-
Return on Capital
10 Years52.74%
5 Years34.73%
3 Years3.78%
Last Year-63.31%
Peers Comparison
Key metrics vs top competitors for Baird Medical Investment Holdings Limited (BDMD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.18 | $48.36M | -1.20 | -39.15% | -121.04% | -76.86% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — | |
| $0.25 | $29.63M | -16.07 | 2.68% | -10.76% | -77.48% | — | |
| $7.41 | $92.58M | -29.64 | 14.52% | -9.05% | -70.95% | — | |
| $45.70 | $378.4M | 53.14 | 16.97% | 14.08% | 22.14% | — | |
| $13.43 | $1.46B | -35.34 | -46.88% | -8.38% | -10.31% | — |
Compare BDMD vs Peers
Baird Medical Investment Holdings Limited (BDMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when BDMD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
BDMD Frequently Asked Questions
Baird Medical Investment Holdings Limited (BDMD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Baird Medical Investment Holdings Limited's revenue?
Baird Medical Investment Holdings Limited (BDMD) reported $59.6M in revenue for fiscal year 2025. This represents a 388% increase from $12.2M in 2019.
How fast is Baird Medical Investment Holdings Limited growing?
Baird Medical Investment Holdings Limited (BDMD) saw revenue decline by 39.2% over the past year.
Is BDMD profitable?
Baird Medical Investment Holdings Limited (BDMD) reported a net loss of $14.8M for fiscal year 2025.
Dividend & Returns
What is BDMD's return on equity?
Baird Medical Investment Holdings Limited (BDMD) has a return on equity (ROE) of -76.9%. Negative ROE indicates the company is unprofitable.
What is Baird Medical Investment Holdings Limited's free cash flow?
Baird Medical Investment Holdings Limited (BDMD) had negative free cash flow of $10.6M in fiscal year 2025, likely due to heavy capital investments.